It was further postulated that H. pylori infection may promote non-alcoholic fatty liver disease (NAFLD) through the impact of possible inflammatory stimuli from Gram-negative microaerophilic H. pylori on the portal circulation and via the increase in chronic inflammation, systemic insulin resistance and altered adipocytokine secretion patterns [22,23]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.